Position in NVS
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$11,832,360
+$299,735 QoQ
Shares Held
75,500
0.0% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.08%
of 13F equity value
Holder Rank
#155
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026GABELLI FUNDS LLC holds $287,466,952 across 14 Drug Manufacturers - General names. NVS ranks #9 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
104,112 | $124,875,066 | |
| 2 | MRK |
Merck & Co., Inc.
|
288,700 | $37,097,950 | |
| 3 | JNJ |
Johnson & Johnson
|
127,317 | $32,334,698 | |
| 4 | AMGN |
Amgen Inc
|
55,700 | $20,170,084 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
256,790 | $14,796,239 | |
| 6 | ABBV |
AbbVie Inc.
|
53,250 | $13,399,830 | |
| 7 | OGN |
Organon & Co.
|
954,910 | $12,929,481 | |
| 8 | PFE |
Pfizer Inc
|
501,500 | $12,076,120 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,832,360 | 75,500 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $11,532,625 | 75,500 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $10,409,185 | 75,500 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $9,861,656 | 76,900 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,608,194 | 79,400 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $8,907,252 | 79,900 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $8,222,695 | 84,500 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $9,719,190 | 84,500 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $9,049,100 | 85,000 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $8,318,780 | 86,000 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $8,784,390 | 87,000 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $9,116,470 | 89,500 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $9,031,445 | 89,500 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $8,234,000 | 89,500 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $8,119,440 | 89,500 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $6,802,895 | 89,500 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $7,565,435 | 89,500 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $8,073,000 | 92,000 | Shares | Sole | 2022-05-18 | |
| 2021-12-31 | $8,047,240 | 92,000 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,605,540 | 93,000 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $8,485,320 | 93,000 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $8,120,600 | 95,000 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $9,065,280 | 96,000 | Shares | Sole | 2021-02-05 | |
| 2020-09-30 | $8,609,040 | 99,000 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $8,646,660 | 99,000 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $8,162,550 | 99,000 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||